UK Markets closed

Cosmo Pharmaceuticals N.V. (0RGI.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
47.41+1.32 (+2.87%)
At close: 06:33PM BST
Currency in CHF

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 347.85
52-week low 346.90
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 515M
Implied shares outstanding 6N/A
Float 89.2M
% held by insiders 143.23%
% held by institutions 112.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.85
Trailing annual dividend yield 34.01%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 33.30%
Operating margin (ttm)17.06%

Management effectiveness

Return on assets (ttm)0.99%
Return on equity (ttm)4.75%

Income statement

Revenue (ttm)65.07M
Revenue per share (ttm)3.86
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)32.1M
EBITDA 15.6M
Net income avi to common (ttm)21.67M
Diluted EPS (ttm)-0.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)222.21M
Total cash per share (mrq)13.3
Total debt (mrq)169.92M
Total debt/equity (mrq)33.14
Current ratio (mrq)12.99
Book value per share (mrq)25.89

Cash flow statement

Operating cash flow (ttm)12.61M
Levered free cash flow (ttm)-10.47M